Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement

J Cell Physiol. 2018 Jun;233(6):4935-4948. doi: 10.1002/jcp.26323. Epub 2018 Jan 15.

Abstract

Cigarette smoking is a recognized risk factor for colon cancer and nicotine, the principal active component of tobacco, plays a pivotal role in increasing colon cancer cell growth and survival. The aim of this study was to determine the effect of nicotine on cellular Caco-2 and HCT-8 migration and invasion, focusing on epithelial to mesenchymal transition (EMT) induction, and COX-2 pathway involvement. In both these cell lines, treatment with nicotine increased COX-2 expression and the release of its enzymatic product PGE2 . Moreover, nicotine-stimulated cells showed increased migratory and invasive behavior, mesenchymal markers up-regulation and epithelial markers down-regulation, nuclear translocation of the β-catenin, increase of MMP-2 and MMP-9 activity, and enhanced NF-κB expression. Noticeably, all these effects are largely mediated by COX-2 activity, as simultaneous treatment of both cell lines with nicotine and NS-398, a selective COX-2 inhibitor, greatly reduced the number of migrating and invading cells and reverted nicotine-induced EMT. These findings emphasize that nicotine triggers EMT, leading hence to increased migration and invasiveness of colon cancer cells. Thereby, the use of COX-2 inhibitor drugs might likely counteract nicotine-mediated EMT effects on colon cancer development and progression.

Keywords: COX-2; EMT; colon cancer; invasion; migration; nicotine.

MeSH terms

  • Antigens, CD / metabolism
  • Antineoplastic Agents / pharmacology
  • Caco-2 Cells
  • Cadherins / metabolism
  • Carcinogens / toxicity*
  • Cell Movement / drug effects*
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / enzymology*
  • Colonic Neoplasms / pathology
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Dinoprostone / metabolism
  • Epithelial-Mesenchymal Transition / drug effects*
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness
  • Nicotine / toxicity*
  • Nitrobenzenes / pharmacology
  • Signal Transduction / drug effects
  • Sulfonamides / pharmacology
  • beta Catenin / metabolism

Substances

  • Antigens, CD
  • Antineoplastic Agents
  • CDH1 protein, human
  • CTNNB1 protein, human
  • Cadherins
  • Carcinogens
  • Cyclooxygenase 2 Inhibitors
  • Nitrobenzenes
  • Sulfonamides
  • beta Catenin
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Nicotine
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Dinoprostone